logo

For the Inventor, By the Inventor

Seoul, South Korea

Hk Inno.n Corporation


USPTO Granted Patents = 15



Trademarks = 14

Forward Citations = 0

Loading Chart...
Loading Chart...

72 inventors (with patents filed for the assignee):

goldMedal Kwang Do Choi (5 out of 13 patents)

silverMedal Eun Sun Kim (5 out of 168 patents)

bronzeMedal Min Kyoung Lee (4 out of 5 patents)

4.  Sung Ah Lee (4 out of 7 patents)

5.  Jae Hong Kweon (3 out of 5 patents)

6.  Dongkyu Kim (3 out of 3 patents)

7.  Hyung Chul Yoo (3 out of 3 patents)

8.  Jae Sun Kim (3 out of 3 patents)

9.  Hyuk Woo Lee (3 out of 6 patents)

10.  Jinwoo Jung (2 out of 65 patents)

11.  Dong Hyun Ko (2 out of 12 patents)

12.  Chae Young Ryu (2 out of 2 patents)

13.  SeungPyeong Heo (2 out of 2 patents)

14.  So Young Ki (2 out of 4 patents)

15.  Seunghee Ji (2 out of 3 patents)


15 patents:

1. 12753174 - Crystalline form of heterocyclic compound as protein kinase inhibitor (2026-10-06),
2. 12642788 - Pharmaceutical composition comprising benzimidazole derivative compound (2026-06-02),
3. 12565491 - (Isopropyl-triazolyl)pyridinyl-substituted benzooxazinone or benzothiazinone derivatives and use thereof (2026-03-03),
4. 12358900 - Acid addition salts of benzimidazole derivative (2025-07-15),
5. 12180185 - Compound as protein kinase inhibitor, and pharmaceutical composition comprising thereof (2024-12-31),
6. 12128030 - Pharmaceutical composition comprising antiplatelet agent and gastric acid secretion inhibitor (2024-10-29),
7. 12077523 - N-(isopropyl-triazolyl)pyridinyl)-heteroaryl-carboxamide derivatives and use thereof (2024-09-03),
8. 11912690 - Acid addition salts of benzimidazole derivative (2024-02-27),
9. 11780810 - Intermediates for optically active piperidine derivatives and preparation methods thereof (2023-10-10),
10. 11576898 - Preparation containing benzimidazole derivative (2023-02-14),
11. 11535610 - Acid addition salts of benzimidazole derivative (2022-12-27),
12. 11524968 - Heterocyclic compound as a protein kinase inhibitor (2022-12-13),
13. 11254641 - Intermediates for optically active piperidine derivatives and preparation methods thereof (2022-02-22),
14. 11033532 - Uses of benzimidazole derivative for nocturnal acid breakthrough (2021-06-15),
15. 10828253 - Composition for injection (2020-11-10),
Company Overview
Hk Inno.n Corporation, based in Seoul, South Korea, specializes in the development and manufacturing of innovative medical devices and healthcare solutions. The company focuses on enhancing patient care through advanced technologies, including diagnostic tools and therapeutic equipment. With a commitment to research and development, Hk Inno.n aims to address critical healthcare challenges and improve clinical outcomes, positioning itself as a key player in the medical technology landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

15 Patents

#281 in Seoul

#779 in South Korea

#39,881 in the World

Seoul, KR
Seoul, South Korea

Hk Inno.n Corporation

Forward Citations = 0

72 inventors:

goldMedal Kwang Do Choi (5 out of 13 patents)

silverMedal Eun Sun Kim (5 out of 168 patents)

bronzeMedal Min Kyoung Lee (4 out of 5 patents)

4.  Sung Ah Lee (4 out of 7 patents)

5.  Jae Hong Kweon (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hk Inno.n Corporation. Retrieved from https://idiyas.com/company/hk-inno-n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…